| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Pietro Tiraboschi, David P Salmon, Lawrence A Hansen, Richard C Hofstetter, Leon J Thal, Jody Corey-Bloo. What best differentiates Lewy body from Alzheimer's disease in early-stage dementia? Brain : a journal of neurology. vol 129. issue Pt 3. 2006-03-15. PMID:16401618. |
to determine which clinical feature(s) [among visual hallucinations (vh), extrapyramidal signs (eps) and visuospatial impairment] in the earliest stages of disease best predicted a diagnosis of dementia with lewy bodies (dlb) at autopsy, first-visit data of 23 pathologically proven dlb and 94 alzheimer's disease cases were compared. |
2006-03-15 |
2023-08-12 |
Not clear |
| Sebastiaan Engelborghs, Bart Dermaut, Peter Mariën, Anoek Symons, Ellen Vloeberghs, Karen Maertens, Nore Somers, Johan Goeman, Rosa Rademakers, Marleen Van den Broeck, Barbara Pickut, Marc Cruts, Christine Van Broeckhoven, Peter P De Dey. Dose dependent effect of APOE epsilon4 on behavioral symptoms in frontal lobe dementia. Neurobiology of aging. vol 27. issue 2. 2006-03-14. PMID:16399213. |
patients with alzheimer's disease (ad) (n=186), frontotemporal dementia (ftd) (n=29), mixed dementia (mxd) (n=28), dementia with lewy bodies (dlb) (n=11) and parkinson's disease dementia (pdd) (n=7) were included. |
2006-03-14 |
2023-08-12 |
Not clear |
| José Luis Albasanz, Esther Dalfó, Isidro Ferrer, Mairena Martí. Impaired metabotropic glutamate receptor/phospholipase C signaling pathway in the cerebral cortex in Alzheimer's disease and dementia with Lewy bodies correlates with stage of Alzheimer's-disease-related changes. Neurobiology of disease. vol 20. issue 3. 2006-03-09. PMID:15949941. |
therefore, group i mglur dysfunction may be implicated in the pathogenesis of cognitive impairment and dementia in common form of dlb and pure ad. |
2006-03-09 |
2023-08-12 |
Not clear |
| Sally L Pimlott, Margaret Piggott, Clive Ballard, Ian McKeith, Robert Perry, Simon Kometa, Jonathan Owens, David Wyper, Elaine Perr. Thalamic nicotinic receptors implicated in disturbed consciousness in dementia with Lewy bodies. Neurobiology of disease. vol 21. issue 1. 2006-03-09. PMID:16023355. |
disturbances of consciousness (doc) are common in dementia with lewy bodies (dlb). |
2006-03-09 |
2023-08-12 |
Not clear |
| Sally L Pimlott, Margaret Piggott, Clive Ballard, Ian McKeith, Robert Perry, Simon Kometa, Jonathan Owens, David Wyper, Elaine Perr. Thalamic nicotinic receptors implicated in disturbed consciousness in dementia with Lewy bodies. Neurobiology of disease. vol 21. issue 1. 2006-03-09. PMID:16023355. |
5-[125i]-a-85380 binding, primarily reflecting the alpha4beta2 subtype, was compared in 16 dlb patients with doc and 6 without doc, matched for duration and severity of dementia. |
2006-03-09 |
2023-08-12 |
Not clear |
| Lin Lu, Dianne M Camp, David A Loeffler, Peter A LeWit. Lack of evidence for Nocardia asteroides in brain specimens from Lewy body-containing disorders. Microbial pathogenesis. vol 39. issue 5-6. 2006-02-27. PMID:16257505. |
this study explored the possible connection between nocardia and two lewy body-containing disorders, pd and dementia with lewy bodies (dlb). |
2006-02-27 |
2023-08-12 |
human |
| Alan J Thomas, David J Burn, Elise N Rowan, Elizabeth Littlewood, Jane Newby, David Cousins, Sanjeet Pakrasi, Jonathan Richardson, Jonathan Sanders, Ian G McKeit. A comparison of the efficacy of donepezil in Parkinson's disease with dementia and dementia with Lewy bodies. International journal of geriatric psychiatry. vol 20. issue 10. 2006-02-22. PMID:16163744. |
parkinson's disease with dementia (pdd) and dementia with lewy bodies (dlb) overlap in phenomenology and neurochemical deficits. |
2006-02-22 |
2023-08-12 |
Not clear |
| Nadeem H Bhanji, Serge Gauthie. Emergent complications following donepezil switchover to galantamine in three cases of dementia with Lewy bodies. The Journal of neuropsychiatry and clinical neurosciences. vol 17. issue 4. 2006-02-21. PMID:16387998. |
delayed disease progression and symptomatic improvement occur with cholinesterase inhibitors (cheis) in dementia with lewy bodies (dlb). |
2006-02-21 |
2023-08-12 |
Not clear |
| M Plotkin, H Amthauer, S Klaffke, A Kühn, L Lüdemann, G Arnold, K-D Wernecke, A Kupsch, R Felix, S Ven. Combined 123I-FP-CIT and 123I-IBZM SPECT for the diagnosis of parkinsonian syndromes: study on 72 patients. Journal of neural transmission (Vienna, Austria : 1996). vol 112. issue 5. 2006-02-16. PMID:15375677. |
in the follow-up, the patients were diagnosed as having parkinson's disease (pd, n = 25), dementia with lewy bodies (dlb, n = 6), multiple system atrophy (msa, n = 13), progressive supranuclear palsy (psp, n = 8), corticobasal degeneration (cbd, n = 9), and essential tremor (et, n = 11). |
2006-02-16 |
2023-08-12 |
Not clear |
| Takeshi Iwatsubo, Genta Ito, Sho Takatori, Yoko Hannno, Tomoki Kuwahar. [Pathogenesis of Parkinson's disease: implications from familial Parkinson's disease]. Rinsho shinkeigaku = Clinical neurology. vol 45. issue 11. 2006-02-15. PMID:16447757. |
the deposition of alpha-synuclein (as), a product of pathogenic gene for dominantly inherited familial parkinson's disease (pd; park1), as fibrillary aggregates like lewy bodies (lb), is a hallmark lesion of a set of neurodegenerative disorders termed synucleinopathies, including sporadic pd and dementia with lewy bodies (dlb). |
2006-02-15 |
2023-08-12 |
Not clear |
| C W C Tam, E J Burton, I G McKeith, D J Burn, J T O'Brie. Temporal lobe atrophy on MRI in Parkinson disease with dementia: a comparison with Alzheimer disease and dementia with Lewy bodies. Neurology. vol 64. issue 5. 2006-02-09. PMID:15753423. |
to investigate the extent of medial temporal lobe atrophy (mta) on mri in parkinson disease (pd) with and without dementia compared with alzheimer disease (ad) and dementia with lewy bodies (dlb) and to determine whether mta correlates with cognitive impairment in pd and pd dementia (pdd). |
2006-02-09 |
2023-08-12 |
Not clear |
| Sean J Colloby, E David Williams, David J Burn, Jim J Lloyd, Ian G McKeith, John T O'Brie. Progression of dopaminergic degeneration in dementia with Lewy bodies and Parkinson's disease with and without dementia assessed using 123I-FP-CIT SPECT. European journal of nuclear medicine and molecular imaging. vol 32. issue 10. 2006-01-31. PMID:15931516. |
the objective of this study was to investigate the rate of progression of nigrostriatal dopaminergic loss in subjects with dementia with lewy bodies (dlb), parkinson's disease (pd) and pd with dementia (pdd) using serial 123i-fp-cit spect imaging. |
2006-01-31 |
2023-08-12 |
human |
| Michael J Firbank, David J Burn, Ian G McKeith, John T O'Brie. Longitudinal study of cerebral blood flow SPECT in Parkinson's disease with dementia, and dementia with Lewy bodies. International journal of geriatric psychiatry. vol 20. issue 8. 2006-01-31. PMID:16035122. |
people with parkinson's disease (pd) have an increased risk of developing dementia (pdd), which often has clinical features similar to dementia with lewy bodies (dlb). |
2006-01-31 |
2023-08-12 |
Not clear |
| Nicola T Lautenschlager, Ralph N Martin. Common versus uncommon causes of dementia. International psychogeriatrics. vol 17 Suppl 1. 2006-01-31. PMID:16240481. |
this paper highlights why uncommon dementias due to genetic mutations, although marginal in terms of prevalence numbers in the total population, are of significance in the quest to unravel the underlying cause of common dementias such as alzheimer's disease (ad), dementia with lewy bodies (dlb), frontotemporal dementias (ftd) and vascular dementia (vad). |
2006-01-31 |
2023-08-12 |
Not clear |
| Laura Parkkinen, Tuula Pirttilä, Markku Tervahauta, Irina Alafuzof. Widespread and abundant alpha-synuclein pathology in a neurologically unimpaired subject. Neuropathology : official journal of the Japanese Society of Neuropathology. vol 25. issue 4. 2006-01-27. PMID:16382779. |
we compared neuronal and glial components in this neurologically unimpaired subject with a patient with a clinical syndrome of dementia with lewy bodies (dlb) by using a range of antigenic determinants and an in situ end-labeling technique. |
2006-01-27 |
2023-08-12 |
human |
| H Braak, U Rüb, E N H Jansen Steur, K Del Tredici, R A I de Vo. Cognitive status correlates with neuropathologic stage in Parkinson disease. Neurology. vol 64. issue 8. 2006-01-20. PMID:15851731. |
none had received the clinical diagnosis of dementia with lewy bodies (dlb). |
2006-01-20 |
2023-08-12 |
Not clear |
| David J Bur. Update on dementia with Lewy bodies. Current neurology and neuroscience reports. vol 5. issue 5. 2006-01-20. PMID:16131416. |
dementia with lewy bodies (dlb) presents to a range of specialists and involves a number of management challenges. |
2006-01-20 |
2023-08-12 |
Not clear |
| Julia Zaccai, Cherie McCracken, Carol Brayn. A systematic review of prevalence and incidence studies of dementia with Lewy bodies. Age and ageing. vol 34. issue 6. 2006-01-19. PMID:16267179. |
substantial variation in the prevalence of dementia with lewy bodies (dlb) has been reported with estimates ranging from 0 to 26.3% of all dementia cases, potentially making it the second most common dementia subtype. |
2006-01-19 |
2023-08-12 |
Not clear |
| K Kantarci, R C Petersen, B F Boeve, D S Knopman, D F Tang-Wai, P C O'Brien, S D Weigand, S D Edland, G E Smith, R J Ivnik, T J Ferman, E G Tangalos, C R Jac. 1H MR spectroscopy in common dementias. Neurology. vol 63. issue 8. 2006-01-18. PMID:15505154. |
to determine the 1h mr spectroscopic (mrs) findings and intergroup differences among common dementias: alzheimer disease (ad), vascular dementia (vad), dementia with lewy bodies (dlb), and frontotemporal lobar degeneration (ftld). |
2006-01-18 |
2023-08-12 |
Not clear |
| Ippolita Cantuti-Castelvetri, Jochen Klucken, Martin Ingelsson, Karunya Ramasamy, Pamela J McLean, Matthew P Frosch, Bradley T Hyman, David G Standaer. Alpha-synuclein and chaperones in dementia with Lewy bodies. Journal of neuropathology and experimental neurology. vol 64. issue 12. 2006-01-18. PMID:16319716. |
the protein alpha-synuclein (asyn) is thought to be involved in the development of dementia with lewy bodies (dlb). |
2006-01-18 |
2023-08-12 |
human |